← Scroll for more →
AN2 Therapeutics, Inc. (ANTX)
Pharmaceutical Preparations
Latest Price
$4.53
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
2.11
P/B Ratio
2.15
Institutional Ownership
67.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 3.15M | $15.0M | 8.69% | -- | 2026-06-30 |
| Commodore Capital LP | 2.93M | $14.0M | 8.08% | +600.0K | 2026-06-30 |
| Millennium Management LLC | 2.32M | $11.0M | 6.39% | +96.2K | 2026-06-30 |
| BlackRock, Inc. | 1.67M | $8.0M | 4.59% | +1.35M | 2026-06-30 |
| Spruce Street Capital LP | 1.66M | $8.0M | 4.57% | -- | 2026-06-30 |
| Almitas Capital LLC | 1.47M | $7.0M | 4.05% | -10.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.24M | $5.0M | 3.41% | +227.6K | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 1.00M | $4.0M | 2.75% | -- | 2026-06-30 |
| Citadel Advisors LLC | 952.0K | $4.0M | 2.62% | +796.8K | 2026-06-30 |
| Boxer Capital Management, LLC | 749.0K | $3.0M | 2.06% | -- | 2026-06-30 |